Alembic Pharma Q4 results: reports consolidated net profit  of Rs 225 crores

Alembic Pharma Q4 results: reports consolidated net profit  of Rs 225 crores

Alembic Pharma Q4 results: reports consolidated net profit  of Rs 225 crores

Alembic Pharma Q4 results: It is one of the largest multinational pharmaceutical companies in India located in Vadodara, Gujarat. The company manufactures various pharmaceutical products, pharmaceutical substances, and intermediates. The manufacturing plant located in Panelav, Karakhadi in Gujarat and Sikkim.

Meanwhile, the shares of the Alembic Pharma Ltd on Friday jumped almost 12% in the stock market. The main reason for this is the company reported its Q4 results on Thursday. The company posted its consolidated net profit of Rs 224.93 crores with an almost 81% increase in this quarter ended in March. Whereas, the company also posted its consolidated net profit of Rs 124 crores in the same quarter last fiscal year. The main reason for the increase in companies’ profit is due to the robust sales in International markets.

Besides, the company also posted its total revenue from operations increased to Rs 1,206.83 crores in this quarter. Whereas, the companies revenue growth of Rs 926.95 crores in the same quarter last year. The company also posted its financial year profit raised to Rs 829.12 crores compared to Rs 584.37 crores last year.

However, the financial revenue of the company stood at Rs 4,605.75 crores in this quarter ended in March. While the revenue of the company stood at 3,934.68 crores in the same quarter last fiscal year.

MD Pranav Amin, Alembic Pharmaceuticals said, “It was one of the remarkable years for the company with almost the highest revenue and profit ever. This was led by strong growth in the US generics business. During the fourth quarter, we saw our India and rest of world (ROW) business also getting back to robust growth,”

On Friday, April 24, the shares of Alembic Pharma Ltd reported a bullish trend in the stock market. The company gained 79.25 points with an 11.34% increase and reached 769.50 INR. While in BSE, the company gained 71.45 points with a 10.23% increase and reached 770.00 INR.

The early trend of both Sensex and Nifty reported a bearish trend in the stock market on Friday after the bullish trend in the last session. The Sensex is trading below 32,000 level, and Nifty is trading below the 9,200 level in the stock market. The Sensex lost 110.78 points with a 0.34% decrease and reached a 31,749.76 level. While Nifty lost 47.45 points with a 0.51% decrease and reached 9,266.45 level.

On the other side, the number of coronavirus cases in India reached 23,077 as of Friday, April 24, and deaths reached 718.

In the border market, the S&P BSE Smallcap index reported a bearish trend in the stock market on Friday. It lost 77.72 points with a 0.72% decrease and reached a 10,707.29 level. The S&P BSE Midcap index lost 100.09 points with a 0.86% decrease and reached an 11,572.85 level. While Nifty Bank lost 347.90 with a 1.89% decrease and reached 19,885.85 level.

Top Gainers on April 24: Reliance, Hero Motocorp, Sun Pharma, ONGC, and Britannia are the top gainers in the stock market. 

Top Losers on April 24: Zee Entertainment, Bharti Infratel, Bajaj Finance, Bajaj Finserv, and Axis Bank are the top losers in the stock market.

Related posts

Apollo Hospitals Enterprise shares increased on July 13th

nagalavanya

FMCG shares on March 31st; Britannia Limited rose almost 9%

Tarun

IT shares drop; Tata Elxsi falls by over 5%: Stocks

nagalavanya